StockNews.com Begins Coverage on Trevena (NASDAQ:TRVN)
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “neutral” rating and set a $5.00 price target on shares of Trevena in a report on Thursday, November 14th. […]
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “neutral” rating and set a $5.00 price target on shares of Trevena in a report on Thursday, November 14th. […]
